BackSAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) Overview

SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) Net Tangible Assets

Latest net tangible assets for BCYPU: $230M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$227.25M

Peer average

Loading

SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) Net Tangible Assets History

Loading

SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) vs. peers: Net Tangible Assets Comparison

Loading

SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) (BCYPU) FAQ

As of the most recent data (March 2026), BCYPU shows a net tangible assets of $230M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BCYPU's net tangible assets is now $230M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) is outperforming or lagging.

Tracking BCYPU's net tangible assets over time shows whether SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) is scaling, shrinking, or reshaping that part of the business. The current reading is $230M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $230M) with ownership activity and broader fundamentals.